Skip to main content
PMC home page
The British Journal of Venereal Diseases logoLink to The British Journal of Venereal Diseases
. 1970 Feb;46(1):34–36. doi: 10.1136/sti.46.1.34

Sulphamethoxazole combined with 2-4-diamino-pyrimidines in the treatment of gonorrhoea.

D J Wright, A S Grimble
PMCID: PMC1048020  PMID: 4907521

Full text

PDF
35

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALMEIDA J. D., HOWATSON A. F., WILLIAMS M. G. Electron microscope study of human warts; sites of virus production and nature of the inclusion bodies. J Invest Dermatol. 1962 Jun;38:337–345. [PubMed] [Google Scholar]
  2. Almeida J. D., Goffe A. P. Antibody to wart virus in human sera demonstrated by electron microscopy and precipitin tests. Lancet. 1965 Dec 11;2(7424):1205–1207. doi: 10.1016/s0140-6736(65)90633-1. [DOI] [PubMed] [Google Scholar]
  3. BLANK H., BUERK M., WEIDMAN F. The nature of the inclusion body of verruca vulgaris; a histochemical study of nucleotids. J Invest Dermatol. 1951 Jan;16(1):19–30. doi: 10.1038/jid.1951.4. [DOI] [PubMed] [Google Scholar]
  4. BUNTING H. Close-packed array of virus-like particles within cells of a human skin papilloma. Proc Soc Exp Biol Med. 1953 Nov;84(2):327–332. doi: 10.3181/00379727-84-20636. [DOI] [PubMed] [Google Scholar]
  5. CHARLES A. Electron microscope observations on the human wart. Dermatologica. 1960 Oct;121:193–203. doi: 10.1159/000255270. [DOI] [PubMed] [Google Scholar]
  6. CRAWFORD L. V., CRAWFORD E. M. A COMPARATIVE STUDY OF POLYOMA AND PAPILLOMA VIRUSES. Virology. 1963 Oct;21:258–263. doi: 10.1016/0042-6822(63)90265-4. [DOI] [PubMed] [Google Scholar]
  7. Csonka G. W., Knight G. J. Therapeutic trial of trimethoprim as a potentiator of sulphonamides in gonorrhoea. Br J Vener Dis. 1967 Sep;43(3):161–165. doi: 10.1136/sti.43.3.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GOLDSCHMIDT H., KLIGMAN A. M. Experimental inoculation of humans with ectodermotropic viruses. J Invest Dermatol. 1958 Sep;31(3):175–182. [PubMed] [Google Scholar]
  9. HORNE R. W., WILDY P. Symmetry in virus architecture. Virology. 1961 Nov;15:348–373. doi: 10.1016/0042-6822(61)90366-x. [DOI] [PubMed] [Google Scholar]
  10. HOWATSON A. F., NAGAI M., ZURHEIN G. M. POLYOMA-LIKE VIRIONS IN HUMAN DEMYELINATING BRAIN DISEASE. Can Med Assoc J. 1965 Aug 28;93:379–386. [PMC free article] [PubMed] [Google Scholar]
  11. HURLY M. G. Potentiation of pyrimethamine by sulphadiazine in human malaria. Trans R Soc Trop Med Hyg. 1959 Sep;53:412–413. doi: 10.1016/0035-9203(59)90044-6. [DOI] [PubMed] [Google Scholar]
  12. MELCZER N. UBER DIE AETIOLOGISCHE IDENTITAET DER GEWOEHNLICHEN WARZEN UND SPITZEN KONDYLOME. Hautarzt. 1965 Apr;16:150–153. [PubMed] [Google Scholar]
  13. MELNICK J. L. Papova virus group. Science. 1962 Mar 30;135(3509):1128–1130. doi: 10.1126/science.135.3509.1128. [DOI] [PubMed] [Google Scholar]
  14. STONE R. S., SHOPE R. E., MOORE D. H. Electron microscope study of the development of the papilloma virus in the skin of the rabbit. J Exp Med. 1959 Oct 1;110:543–546. doi: 10.1084/jem.110.4.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. WETTINGFELD R. F., ROWE J., EYLES D. E. Treatment of toxoplasmosis with pyrimethamine (daraprim) and triple sulfonamide. Ann Intern Med. 1956 Mar;44(3):557–564. doi: 10.7326/0003-4819-44-3-557. [DOI] [PubMed] [Google Scholar]
  16. WILLIAMS M. G., HOWATSON A. F., ALMEIDA J. D. Morphological characterization of the virus of the human common wart (verruca vulgaris). Nature. 1961 Mar 18;189:895–897. doi: 10.1038/189895a0. [DOI] [PubMed] [Google Scholar]
  17. Wright D. J. Why sulphonamides, when combined with 2-4-diamino-pyrimidines, are effective in sulphonamide-resistant gonorrhoea. Guys Hosp Rep. 1969;118(2):287–291. [PubMed] [Google Scholar]
  18. ZIMMER S. MORPHOLOGISCHER VIRUSNACHWEIS BEI SPITZEN KONDYLOMEN. Zentralbl Gynakol. 1964 Aug 8;86:1116–1119. [PubMed] [Google Scholar]

Articles from British Journal of Venereal Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES